- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: recombinant human erythropoietin (rhEpo)
Total 1264 results
-
RevimmuneWashington University School of MedicineTerminatedMycobacterium Infections, NontuberculousUnited States
-
Swedish Orphan BiovitrumCompletedSanfilippo Syndrome Type A (MPS IIIA)United States, Germany, Turkey
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedLymphedema | Malignant NeoplasmUnited States
-
Novo Nordisk A/SCompletedOther Haemostasis Disorder | Haemorrhagic CystitisUnited States
-
Novo Nordisk A/STerminatedAcquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary BypassUnited States, Spain, Germany, Sweden, United Kingdom, Argentina, Italy, Brazil, Denmark, France, India, Malaysia, Singapore, South Africa
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance, United Kingdom, Spain, Israel, Poland, Turkey, Hungary
-
Novo Nordisk A/SCompletedObservational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII DeficiencyCongenital Bleeding Disorder | Congenital FVII DeficiencyJapan
-
Digna Biotech S.L.Unknown
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Nanfang Hospital of Southern Medical UniversityThe Third Affiliated Hospital of Southern Medical University; The Second People... and other collaboratorsNot yet recruitingPneumonia | Thrombocytopenia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); RevimmuneWithdrawnRecombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood TransplantationUmbilical Cord Blood Transplant
-
Zymenex A/SCompleted
-
Novo Nordisk A/SCompletedCirrhosis | Acquired Bleeding DisorderGermany, United Kingdom, Spain, Taiwan, France, Italy, Austria, Czech Republic, Poland, Denmark, Finland, Hong Kong
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderIndia, Spain, Canada, Finland, Germany, Israel, Italy, Netherlands, Singapore, Switzerland, Taiwan
-
Novo Nordisk A/SWithdrawnTrauma | Acquired Bleeding DisorderUnited States
-
Zensun Sci. & Tech. Co., Ltd.Recruiting
-
Eisai Inc.Halozyme TherapeuticsTerminated
-
Bio Sidus SARecruiting
-
Hoffmann-La RocheCompletedGlaucomaUnited Kingdom, Belgium, Czechia, Netherlands
-
Baxter Healthcare CorporationPPD; Halozyme TherapeuticsCompleted
-
Peking University People's HospitalUnknownCorticosteroid-resistant or Relapsed ITPChina
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageFinland, Singapore, Australia, Spain, Denmark, Germany, Italy, Taiwan, United Kingdom
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCCompletedMucopolysaccharidosis I | Scheie Syndrome | Hurler's Syndrome | Hurler-Scheie SyndromeBrazil, Canada
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCCompletedMucopolysaccharidosis I | Scheie Syndrome | Hurler Syndrome | Hurler-Scheie SyndromeJapan
-
agnes chenUniversity of California, Los Angeles; National Institute of Neurological Disorders... and other collaboratorsTerminatedMucopolysaccharidosis I | Cognitive DeclineUnited States
-
Chiesi Farmaceutici S.p.A.Completed
-
Zymenex A/SEuropean CommissionCompletedAlpha-MannosidosisBelgium, Denmark, Spain, United Kingdom
-
Joyce FoxUltragenyx Pharmaceutical IncNo longer availableMucopolysaccharidosis Type 7United States
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageUnited States
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderGermany, Austria, Israel, France, Canada, Singapore, South Africa, Australia, United Kingdom
-
Baylor College of MedicineCompleted
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCCompletedMucopolysaccharidosis I | Scheie Syndrome | Hurler Syndrome | Hurler-Scheie SyndromeNetherlands, France, Germany, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Chiesi Farmaceutici S.p.A.CompletedAlpha-MannosidosisFrance
-
ShireTakeda Development Center Americas, Inc.Active, not recruitingMetachromatic Leukodystrophy (MLD)Denmark, Germany, Japan, Australia, France, Brazil, Czechia
-
ShireCompletedMucopolysaccharidosis (MPS)United Kingdom, Netherlands
-
ShireCompletedSanfilippo SyndromeUnited States, Spain, United Kingdom, Argentina, France, Germany, Italy, Netherlands
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 DisorderUnited States, Germany, Italy, United Kingdom
-
Shanghai Gebaide Biotechnology Co., Ltd.UnknownNon-small-cell Lung Cancer (NSCLC) Stage IVChina
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCTerminatedMucopolysaccharidosis I | Hurler's Syndrome | Hurler-Scheie Syndrome | ScheieItaly
-
ShireTerminatedSanfilippo Syndrome | Mucopolysaccharidosis (MPS)United States, United Kingdom, Spain, Germany, France, Italy, Netherlands
-
Beijing Northland Biotech. Co., Ltd.Completed
-
Beijing Northland Biotech. Co., Ltd.Completed
-
University of MiamiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Alexion PharmaceuticalsCompletedMucopolysaccharidosis IIIBUnited States, United Kingdom, Spain
-
BioMarin PharmaceuticalApproved for marketingCLN2 DiseaseUnited Kingdom, United States, Germany, Italy
-
Green Cross CorporationICON Clinical ResearchTerminated
-
ProtalixCompleted